vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and WORKIVA INC (WK). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $238.9M, roughly 1.5× WORKIVA INC). WORKIVA INC runs the higher net margin — 4.9% vs -0.8%, a 5.7% gap on every dollar of revenue. On growth, WORKIVA INC posted the faster year-over-year revenue change (19.5% vs 9.4%). WORKIVA INC produced more free cash flow last quarter ($50.7M vs $36.1M). Over the past eight quarters, WORKIVA INC's revenue compounded faster (16.6% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Workiva, Inc. is a global software-as-a-service (SaaS) company. It provides a cloud-based connected and reporting compliance platform that enables the use of connected data and automation of reporting across finance, accounting, risk, and compliance.
ASIX vs WK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $238.9M |
| Net Profit | $-2.8M | $11.8M |
| Gross Margin | 7.6% | 80.7% |
| Operating Margin | -0.7% | 3.3% |
| Net Margin | -0.8% | 4.9% |
| Revenue YoY | 9.4% | 19.5% |
| Net Profit YoY | -892.9% | 234.0% |
| EPS (diluted) | $-0.11 | $0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $238.9M | ||
| Q3 25 | $374.5M | $224.2M | ||
| Q2 25 | $410.0M | $215.2M | ||
| Q1 25 | $377.8M | $206.3M | ||
| Q4 24 | $329.1M | $199.9M | ||
| Q3 24 | $398.2M | $185.6M | ||
| Q2 24 | $453.5M | $177.5M | ||
| Q1 24 | $336.8M | $175.7M |
| Q4 25 | $-2.8M | $11.8M | ||
| Q3 25 | $-2.6M | $2.8M | ||
| Q2 25 | $31.4M | $-19.4M | ||
| Q1 25 | $23.3M | $-21.4M | ||
| Q4 24 | $352.0K | $-8.8M | ||
| Q3 24 | $22.3M | $-17.0M | ||
| Q2 24 | $38.9M | $-17.5M | ||
| Q1 24 | $-17.4M | $-11.7M |
| Q4 25 | 7.6% | 80.7% | ||
| Q3 25 | 6.8% | 79.3% | ||
| Q2 25 | 14.3% | 77.0% | ||
| Q1 25 | 14.2% | 76.6% | ||
| Q4 24 | 3.4% | 77.1% | ||
| Q3 24 | 14.4% | 76.5% | ||
| Q2 24 | 17.9% | 76.8% | ||
| Q1 24 | 0.9% | 76.4% |
| Q4 25 | -0.7% | 3.3% | ||
| Q3 25 | -0.9% | -1.5% | ||
| Q2 25 | 7.7% | -10.3% | ||
| Q1 25 | 7.7% | -12.0% | ||
| Q4 24 | -3.9% | -6.7% | ||
| Q3 24 | 7.5% | -11.7% | ||
| Q2 24 | 11.5% | -13.0% | ||
| Q1 24 | -7.0% | -10.4% |
| Q4 25 | -0.8% | 4.9% | ||
| Q3 25 | -0.7% | 1.2% | ||
| Q2 25 | 7.7% | -9.0% | ||
| Q1 25 | 6.2% | -10.4% | ||
| Q4 24 | 0.1% | -4.4% | ||
| Q3 24 | 5.6% | -9.2% | ||
| Q2 24 | 8.6% | -9.9% | ||
| Q1 24 | -5.2% | -6.7% |
| Q4 25 | $-0.11 | $0.21 | ||
| Q3 25 | $-0.10 | $0.05 | ||
| Q2 25 | $1.15 | $-0.35 | ||
| Q1 25 | $0.86 | $-0.38 | ||
| Q4 24 | $0.02 | $-0.15 | ||
| Q3 24 | $0.82 | $-0.31 | ||
| Q2 24 | $1.43 | $-0.32 | ||
| Q1 24 | $-0.65 | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $338.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $-5.4M |
| Total Assets | $1.7B | $1.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $338.8M | ||
| Q3 25 | $23.7M | $315.9M | ||
| Q2 25 | $18.4M | $284.3M | ||
| Q1 25 | $8.3M | $242.0M | ||
| Q4 24 | $19.6M | $301.8M | ||
| Q3 24 | $17.3M | $248.2M | ||
| Q2 24 | $12.1M | $267.9M | ||
| Q1 24 | $20.6M | $296.1M |
| Q4 25 | $815.2M | $-5.4M | ||
| Q3 25 | $818.2M | $-36.9M | ||
| Q2 25 | $823.7M | $-66.5M | ||
| Q1 25 | $794.4M | $-75.7M | ||
| Q4 24 | $774.6M | $-41.7M | ||
| Q3 24 | $766.4M | $-50.8M | ||
| Q2 24 | $746.6M | $-77.7M | ||
| Q1 24 | $713.2M | $-83.2M |
| Q4 25 | $1.7B | $1.5B | ||
| Q3 25 | $1.7B | $1.4B | ||
| Q2 25 | $1.6B | $1.3B | ||
| Q1 25 | $1.6B | $1.3B | ||
| Q4 24 | $1.6B | $1.4B | ||
| Q3 24 | $1.5B | $1.3B | ||
| Q2 24 | $1.5B | $1.2B | ||
| Q1 24 | $1.5B | $1.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $51.0M |
| Free Cash FlowOCF − Capex | $36.1M | $50.7M |
| FCF MarginFCF / Revenue | 10.0% | 21.2% |
| Capex IntensityCapex / Revenue | 7.7% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 4.31× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $138.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $51.0M | ||
| Q3 25 | $26.6M | $46.2M | ||
| Q2 25 | $21.1M | $50.3M | ||
| Q1 25 | $11.4M | $-7.4M | ||
| Q4 24 | $64.2M | $44.0M | ||
| Q3 24 | $57.3M | $18.9M | ||
| Q2 24 | $50.2M | $-14.0K | ||
| Q1 24 | $-36.2M | $24.8M |
| Q4 25 | $36.1M | $50.7M | ||
| Q3 25 | $66.0K | $46.1M | ||
| Q2 25 | $-7.2M | $49.3M | ||
| Q1 25 | $-22.6M | $-8.1M | ||
| Q4 24 | $29.8M | $43.2M | ||
| Q3 24 | $26.8M | $18.7M | ||
| Q2 24 | $16.7M | $-122.0K | ||
| Q1 24 | $-71.6M | $24.6M |
| Q4 25 | 10.0% | 21.2% | ||
| Q3 25 | 0.0% | 20.5% | ||
| Q2 25 | -1.7% | 22.9% | ||
| Q1 25 | -6.0% | -3.9% | ||
| Q4 24 | 9.1% | 21.6% | ||
| Q3 24 | 6.7% | 10.1% | ||
| Q2 24 | 3.7% | -0.1% | ||
| Q1 24 | -21.3% | 14.0% |
| Q4 25 | 7.7% | 0.1% | ||
| Q3 25 | 7.1% | 0.0% | ||
| Q2 25 | 6.9% | 0.5% | ||
| Q1 25 | 9.0% | 0.4% | ||
| Q4 24 | 10.4% | 0.4% | ||
| Q3 24 | 7.7% | 0.1% | ||
| Q2 24 | 7.4% | 0.1% | ||
| Q1 24 | 10.5% | 0.1% |
| Q4 25 | — | 4.31× | ||
| Q3 25 | — | 16.57× | ||
| Q2 25 | 0.67× | — | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 182.29× | — | ||
| Q3 24 | 2.57× | — | ||
| Q2 24 | 1.29× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
WK
| License And Service | $219.3M | 92% |
| XBRL Professional Services | $16.4M | 7% |
| Other Services | $3.2M | 1% |
